OXLCN Q4 2025 Earnings EPS Misses Estimates but Stock Edges Higher OXM Q1 2026 Earnings EPS Misses Estimates by Wide Margin Shares Gain LGIH Q1 2026 Earnings Massive EPS Beat Surprises the Market Prelude Therapeutics Q1 2026 Earnings Significant EPS Beat Amid No Revenue Katapult Holdings Q1 2026 Earnings Massive Profitability Surprise Drives DoubleDigit EPS Beat MNSO Q4 2025 Earnings EPS Surges 88 Above Estimates Despite Revenue Silence Stock Slips